-
PNZ5
- names:
PNZ5
- CAS号:
1629277-36-6
MDL Number: - MF(分子式): C20H18N2O2 MW(分子量): 318.37
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM002938-250mg | 250mg | ¥ 0.00 | ¥ 0.00 | Backorder | ¥ 0.00 | |||
| YZM002938-100mg | 100mg | >97% | ¥ 0.00 | ¥ 0.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 1629277-36-6 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C20H18N2O2 |
| 分子量 Molecular Weight | 318.37 |
| 溶解度Solubility | |
| 性状 | |
| 储藏条件 Storage conditions | 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description. |
PNZ5(CAS:1629277-36-6)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | PNZ5 为一个有效的、异恶唑类的、BET的广泛抑制剂,有着类似(+)-JQ1 的高选择性和强效作用,其对BRD4 |
| Introduction | PNZ5 is a potent and isoxazoleasedpanETinhibitor with high selectivity and potency similar to the wellstablished (+)Q1, with aKDof 5.43 nM for BRD4(1). |
| Application1 | |
| Application2 | |
| Application3 |
PNZ5 为一个有效的、异恶唑类的、BET的广泛抑制剂,有着类似(+)-JQ1 的高选择性和强效作用,其对BRD4(1) 的KD值为 5.43 nM。PNZ5 is a potent and isoxazole-basedpan-BETinhibitor with high selectivity and potency similar to the well-established (+)-JQ1, with aKDof 5.43 nM for BRD4(1)[1].
【1】.Montenegro RC, et al. BET inhibition as a new strategy for the treatment of gastric cancer. Oncotarget. 2016 Jul 12;7(28):43997-44012.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


